Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Toxicology &Pharmacology of Drugs Developed for Cancer
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Aberrant Megakaryopoiesis in the Myeloproliferative Neoplasms
Structural biology of copper homeostasis
Problem-Based Learning for Environmental Health
Role for C Abl Kinase in DNA Damage Induced Responses
Core - Clinical Research Development
Recently added grants:
RR&D Research Career Scientist Award Application
Novel Regenerative Treatment of TBI and Post TBI Depression
Improving exercise capacity in chronic obstructive pulmonary disease patients through uphill walking
Feasibility and Acceptability of The Equus Effect: A Small Randomized Controlled Pilot Study of an Equine-facilitated Therapy
Ethanol & Anxiety: Cellular Mechanisms
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM42200-13-0-1
Application #
7624423
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Toxicology &Pharmacology of Drugs Developed for Cancer
/ Battelle Centers/Pub Health Research & Evaluatn
$1,230,594
NIH 2007
N01 CA
Preclinical Toxicology and Pharmacology of Drugs
Johnson, Jerry /
$1,001,062
NIH 2007
N01 CA
Preclinical Toxicology &Pharmacology of Drugs Developed for Cancer
/
Comments
Be the first to comment on this grant